Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Paysign NASDAQ: PAYS reported record second-quarter revenue, net income and adjusted EBITDA for 2026, driven primarily by continued expansion in its Patient Affordability business and improving utilization in its plasma donor compensation operations.
Paysign, Inc. (PAYS) Q2 2026 Earnings Call Transcript
| CXA Exchange | US Country |
Paysign, Inc. specializes in offering a broad spectrum of prepaid card programs, patient affordability options, digital banking services, and integrated payment processing for a diverse clientele including businesses, consumers, and government institutions. Initially known as 3PEA International, Inc., the company underwent a name change to Paysign, Inc. in April 2019, showcasing its evolution and broadening its focus. Founded in 1995 and operating from its headquarters in Henderson, Nevada, Paysign extends its market presence primarily towards organizations and municipalities in need of efficient payment solutions for various purposes such as rewards, rebates, and payment assistance. This rebranding and strategic positioning reflect Paysign's commitment to innovation in payment solutions.